Children aged between 15 and 18 years old will receive vaccinations from the 3rd of January. Covid Booster doses were approved for doctors, health professionals and frontline employees and people over 60 who have health issues starting on January 10.Prime Minister Narendra Modi
In the midst of the Omicron threat, the prime minister Narendra Modi spoke on Friday to the nation.
In a speech to the nation, he said the decision to begin vaccinating children at the beginning of the new year was taken after consultation with scientists.
Today, Covaxin was cleared for children aged 12 and above by the drug regulatory agency. The decision needs been approved from the federal government. Covaxin is the second vaccination that has been approved by the drug regulator for people who are under 18 following Zydus Cadila’s COVID-19 needle-free vaccine ZyCoV-D.
He also mentioned that “precaution doses” will be introduced for doctors, other health care professionals and front-line workers starting January 10, but not calling it a “booster shot”.
People over 60 who have other health issues will also be given additional doses starting on January 10, based on their doctor’s guidance, he added.
PM Modi stated that global experiences showed the need to take all preventive measures is an effective weapon against Covid. “Coronavirus is not gone… The world is now talking about Omicron. Today is Atal Bihari Vajpayee’s birthday and Christmas, so we decided to announce this step today,” Modi stated.
In light of the increase of Omicron infections, the Prime Minister advised people not to be worried. “In India, many people have been found to be infected with Omicron. I would urge all of you not to panic, be careful and alert. Remember to wash hands and mask,” he added.
India currently has 415 Omicron cases at the time of writing. As the country experiences an increase in Covid cases the Health Ministry said multi-disciplinary central teams will be deployed to 10 states.
Study Launched to Determine the need for COVID Booster Doses
In addition, the Narendra Modi administration also started an investigation to determine the need for booster doses to combat the Covid-19 virus in India.
The multi-centre study, supervised by the department of Biotechnology’s top institute, the Translational Health Science and Technology Institute (THSTI) will aim to encompass more than 3,000 people who taken the dose two times of the Covid-19 vaccine just six months ago. The study, which is sponsored by DBT is a study of three vaccines that are used in India including Covishield, Covaxin and Sputnik V.
The study has been planned to cover four groups -individuals over 40 years old and those who are younger than 40 as well as those infected with covid-19 before vaccination as well as those suffering from other comorbidities.
Hospitals participating in the study have been collecting sample of blood from the Delhi-NCR region, Gurugram as well as Faridabad. “A simple questionnaire has been created to collect the information on their medical history, vaccination status and other clinical information,” the source explained.
The introduction of Omicron Omicron, one of the newer variants of coronavirus, has brought about demands to the administration of booster doses throughout the country. The goal of the booster dosage is to improve the effectiveness of vaccine.
Tag: Booster Covid Vaccine for Doctors